Amjevita, a Biosimilar to Humira, Now Available
Amjevita is supplied as a 40 mg/0.8 mL single-dose prefilled SureClick autoinjector, and as 20 mg/0.4 mL and 40 mg/0.8 mL single-dose prefilled syringes.
Amjevita is supplied as a 40 mg/0.8 mL single-dose prefilled SureClick autoinjector, and as 20 mg/0.4 mL and 40 mg/0.8 mL single-dose prefilled syringes.
Liver disease and cirrhosis now outpace diabetes and stroke as the leading cause of mortality in people aged 25 to 54 years. New survey results shows shortfalls in adoption of national treatment guidelines for liver disease and cirrhosis.
A bidirectional link between inflammatory bowel disease (IBD) and depression was found in a large cohort study; the findings extended to siblings of patients with IBD.
Read updates on effective treatments for IBS, the effects of food allergies on proton pump inhibitor efficacy, and oral microbiome therapy for C difficile and more from DDW 2022.
Researchers conducted a study to evaluate the relationship between the composition and diversity of the gut microbiome and secretor status among patients with acute gastroenteritis due to norovirus infection.
Investigators assessed the efficacy of a novel microbiome therapeutic, SER-109, for the treatment of recurrent C difficile infection.
An increase in pediatric cases of C difficile is linked to use of broad-spectrum antibiotics, recurrent infections, and a growth in highly virulent strains.
Atypical celiac disease may present as dermatitis herpetiformis, anemia, elevated transaminases, short stature, and osteopenia/osteoporosis.
Researchers investigated which patients with distressing and chronic GI complaints also fulfilled criteria for a somatic symptom disorder.
Researchers compared the effects of probiotics vs placebo for the treatment of children with diarrhea secondary to acute gastroenteritis.